Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Nehler

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Circulation|October 12, 2021
Reduction in Acute Limb Ischemia With Rivaroxaban Versus Placebo in Peripheral Artery Disease After Lower Extremity Revascularization: Insights From VOYAGER PADConnie N Hess, E Sebastian Debus, Mark R Nehler, et al.
Journal of Vascular Surgery|February 27, 2021
Popliteal scoring assessment for vascular extremity injuries in trauma studyLeigh Ann O'Banion, Rachel Dirks, Emaad Farooqui, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 29, 2023
Novel Tissue Factor Inhibition for Thromboprophylaxis in COVID-19: Primary Results of the ASPEN-COVID-19 TrialConnie N Hess, Judith Hsia, Ian A Carroll, et al.
Journal of Vascular Surgery|May 23, 2021
Contemporary outcomes of traumatic popliteal artery injury repair from the popliteal scoring assessment for vascular extremity injury in trauma studyLeigh Ann O'Banion, Rachel Dirks, Nallely Saldana-Ruiz, et al.
The New England Journal of Medicine|March 30, 2020
Rivaroxaban in Peripheral Artery Disease after RevascularizationMarc P Bonaca, Rupert M Bauersachs, Sonia S Anand, et al.
Circulation|August 12, 2021
Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD TrialE Sebastian Debus, Mark R Nehler, Nicholas Govsyeyev, et al.
Thrombosis Research|June 11, 2023
Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Rationale and methodology of the CORONA-VTE-Network studyBehnood Bikdeli, Candrika D Khairani, Darsiya Krishnathasan, et al.
Thrombosis Research|April 27, 2024
Low absolute risk of thrombotic and cardiovascular events in outpatient pregnant women with COVID-19Behnood Bikdeli, Darsiya Krishnathasan, Candrika D Khairani, et al.
Journal of Thrombosis and Thrombolysis|March 11, 2025
Predictors of venous thromboembolic events in hospitalized patients with COVID-19Giovanni Scimeca, Darsiya Krishnathasan, Sina Rashedi, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|October 27, 2025
Association between Active Cancer and Risk of Thrombotic and Cardiovascular Outcomes in Outpatients with COVID-19: A CORONA-VTE Network AnalysisBridget McGonagle, Christie Greason, Darsiya Krishnathasan, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Circulation|October 12, 2021
Reduction in Acute Limb Ischemia With Rivaroxaban Versus Placebo in Peripheral Artery Disease After Lower Extremity Revascularization: Insights From VOYAGER PADConnie N Hess, E Sebastian Debus, Mark R Nehler, et al.
Journal of Vascular Surgery|February 27, 2021
Popliteal scoring assessment for vascular extremity injuries in trauma studyLeigh Ann O'Banion, Rachel Dirks, Emaad Farooqui, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 29, 2023
Novel Tissue Factor Inhibition for Thromboprophylaxis in COVID-19: Primary Results of the ASPEN-COVID-19 TrialConnie N Hess, Judith Hsia, Ian A Carroll, et al.
Journal of Vascular Surgery|May 23, 2021
Contemporary outcomes of traumatic popliteal artery injury repair from the popliteal scoring assessment for vascular extremity injury in trauma studyLeigh Ann O'Banion, Rachel Dirks, Nallely Saldana-Ruiz, et al.
The New England Journal of Medicine|March 30, 2020
Rivaroxaban in Peripheral Artery Disease after RevascularizationMarc P Bonaca, Rupert M Bauersachs, Sonia S Anand, et al.
Circulation|August 12, 2021
Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD TrialE Sebastian Debus, Mark R Nehler, Nicholas Govsyeyev, et al.
Thrombosis Research|June 11, 2023
Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Rationale and methodology of the CORONA-VTE-Network studyBehnood Bikdeli, Candrika D Khairani, Darsiya Krishnathasan, et al.
Thrombosis Research|April 27, 2024
Low absolute risk of thrombotic and cardiovascular events in outpatient pregnant women with COVID-19Behnood Bikdeli, Darsiya Krishnathasan, Candrika D Khairani, et al.
Journal of Thrombosis and Thrombolysis|March 11, 2025
Predictors of venous thromboembolic events in hospitalized patients with COVID-19Giovanni Scimeca, Darsiya Krishnathasan, Sina Rashedi, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|October 27, 2025
Association between Active Cancer and Risk of Thrombotic and Cardiovascular Outcomes in Outpatients with COVID-19: A CORONA-VTE Network AnalysisBridget McGonagle, Christie Greason, Darsiya Krishnathasan, et al.
Pageof 7